Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Viral Replication”

101 trials

Showing 20 of 101 results

Not applicableEnded earlyNCT00001651
What this trial is testing

Use of Labeled Glucose to Study Lymphocyte Replication and Survival in HIV-Infected Patients

Who this might be right for
HIVHealthy Volunteers
National Institute of Allergy and Infectious Diseases (NIAID) 54
Early research (Phase 1)Study completedNCT00107549
What this trial is testing

Safety of Recombinant HIV Vaccines in HIV Infected Young Adults on Stable Therapy

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 20
Not applicableStudy completedNCT00002369
What this trial is testing

A Comparison of Epivir Plus Crixivan Combined With Zerit or Retrovir in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Who this might be right for
HIV Infections
Bristol-Myers Squibb 200
Large-scale testing (Phase 3)Study completedNCT00935480
What this trial is testing

IntensVIH: Impact Of Therapy Intensification By An Integrase Inhibitor +/- CCR5 Inhibitor On The Lymphoid Reservoir For Hiv-1 In Chronically Infected Patients

Who this might be right for
HIV Infections
Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer 17
Not applicableUnknownNCT02162797
What this trial is testing

Zinc Supplementation Effect on Immune Recovery in HIV Patients

Who this might be right for
HIVAIDSImmunological Deficiency+2 more
CES University 40
Testing effectiveness (Phase 2)Study completedNCT00007202
What this trial is testing

Safety and Effectiveness of a Three-Drug Combination Treatment for Recently Infected or Converted HIV Patients

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 55
Not applicableStudy completedNCT00884793
What this trial is testing

Pilot Study on the Effect of Adding Raltegravir +/- a Second Drug on HIV Levels in the Gut

Who this might be right for
HIV Infections
University of California, San Francisco 8
Early research (Phase 1)Study completedNCT00000729
What this trial is testing

Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 10
Not applicableStudy completedNCT00051831
What this trial is testing

Effect of an Enfuvirtide-based Anti-HIV Drug Regimen on Latent HIV Reservoirs in Treatment Naive Adults

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 19
Early research (Phase 1)Study completedNCT03430830
What this trial is testing

Evaluate the Pharmacokinetics and Safety of ASC16 Tablets in Healthy Volunteers in China

Who this might be right for
Chronic Hepatitis c
Ascletis Pharmaceuticals Co., Ltd. 12
Large-scale testing (Phase 3)Study completedNCT04824365
What this trial is testing

Sodium Pyruvate Nasal Spray Treatment of COVID-19 Infection

Who this might be right for
COVID-19
Cellular Sciences, inc. 30
Post-approval studies (Phase 4)WithdrawnNCT04936971
What this trial is testing

Introduction of mTor Inhibitors and the Activation of the Cytomegalovirus (CMV) -Specific Cellular Immune Response

Who this might be right for
Kidney TransplantationCytomegalovirus Infections
Edoardo Melilli
Early research (Phase 1)Study completedNCT01240538
What this trial is testing

Viral Therapy in Treating Young Patients With Relapsed or Refractory Solid Tumors

Who this might be right for
Unspecified Childhood Solid Tumor, Protocol Specific
National Cancer Institute (NCI) 26
Testing effectiveness (Phase 2)Study completedNCT00298233
What this trial is testing

High-Dose Versus Standard-Dose Oseltamivir to Treat Severe Influenza and Avian Influenza

Who this might be right for
InfluenzaAvian InfluenzaSevere Influenza
National Institute of Allergy and Infectious Diseases (NIAID) 326
Early research (Phase 1)Study completedNCT00000735
What this trial is testing

A Clinical Trial To Evaluate the Toxicity and Antiviral Effects of a Range of Doses of Ampligen in p24 Antigen Positive HIV-Infected Patients With AIDS or ARC

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 12
Not applicableStudy completedNCT01048372
What this trial is testing

Observational Study of Blood Treated With Cytolin

Who this might be right for
HIV Infections
CytoDyn, Inc. 20
Not applicableStudy completedNCT00001650
What this trial is testing

Use of Bromodeoxyuridine to Study White Blood Cell Replication and Survival in HIV-Infected Patients

Who this might be right for
HIV InfectionAcquired Immunodeficiency Syndrome
National Institute of Allergy and Infectious Diseases (NIAID) 56
Testing effectiveness (Phase 2)Study completedNCT04381884
What this trial is testing

Ivermectin Effect on SARS-CoV-2 Replication in Patients With COVID-19

Who this might be right for
COVID-19 Drug Treatment
Laboratorio Elea Phoenix S.A. 45
Testing effectiveness (Phase 2)Study completedNCT00001025
What this trial is testing

Evaluation of Patients Who Have Not Had Success With Zidovudine

Who this might be right for
HIV Infections
National Institute of Allergy and Infectious Diseases (NIAID) 120
Post-approval studies (Phase 4)UnknownNCT00840762
What this trial is testing

A Comparison of Virco®TYPE HIV-1 Testing Versus Expert Interpretation of Genotypic Results for Control of HIV-1 Replication

Who this might be right for
HIV-1HIV Infections
Ruth M. Rothstein CORE Center 756
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation